MEDP Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MEDP shares is 804, representing 85.72% of the company's common stock.

FISHER ASSET MANAGEMENT, LLC, in the last quarter, reduced its stake in MEDP by -0.11% restricting it's holding to 119.96 thousand shares of worth nearly $48.48M. SMITH GROUP ASSET MANAGEMENT, LLC also lessened -6.4% of the MEDP shares from its portfolio, reducing its holding to 106.62 thousand shares of worth $43.09M. ENVESTNET ASSET MANAGEMENT INC also shunned MEDP shares holding by -5.42% last quarter which brought its holding to 105.9 thousand shares worth $42.80M.

As per its latest 13F filing, QUBE RESEARCH & TECHNOLOGIES LTD increased its stake in MEDP by 212.58% in the last quarter. The institutional holder raised its holding to 106.05 thousand shares having worth more than $42.86M. NUVEEN ASSET MANAGEMENT, LLC also added 0.73% more shares of MEDP to its portfolio, raising its holding to 101.18 thousand shares of worth $40.89M. SUSQUEHANNA PORTFOLIO STRATEGIES, LLC also increased its MEDP shares holding by 100% which brought its holding to 96.1 thousand shares worth $38.84M.

The insider with the most stakes in MEDP is Medpace Investors, LLC , 10 percent owner at the company. Additionally, MEDP stock is highly held by CEO Troendle August J. and General Counsel & Corp. Secy. EWALD STEPHEN P among others.

Company executives, directors, and other insiders own 17.8% percent of Medpace Holdings, Inc.'s stock. Within the last six months, there have been 19 transaction(s) in which MEDP insiders have sold stock, totaling 163.79K shares. Insiders that have sold shares include KRAFT ROBERT O., BURWIG SUSAN E, and TROENDLE AUGUST J..

There have been 0 transaction(s) during the past 6-months in which Medpace Holdings, Inc. insiders have bought stock, totalling 0 shares

Around 10.75M Medpace Holdings, Inc. shares are held by insiders, which represents about 17.8% of MEDP stock.

MEDP 10 percent owner, Medpace Investors, LLC holds the largest portfolio of the company's shares. MEDP shares owned by Medpace total nearly 4.73 million.

FISHER ASSET MANAGEMENT, LLC is the largest institutional owner in MEDP which holds 119.96 thousand shares worth $48.48M or 0.39% of the total MEDP shares outstanding followed by SMITH GROUP ASSET MANAGEMENT, LLC with ownership of 106.62 thousand shares representing 0.35% of the MEDP ownership. QUBE RESEARCH & TECHNOLOGIES LTD is the third largest stakeholder with 106.05 thousand shares or 0.35% of the ownership worth more than $42.86M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MEDP is concerned, it is a stock which is optionable.

Number of MEDP shares short is 956.00K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 31.00M shares of MEDP are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MEDP has 25.39M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MEDP is 2.73.